Skip to content

ICU医疗

US · ICUI #2287 按市值排名 上市于 1970
162.99 -4.24 -2.54%
实时 - 追踪5344个代码 - 心跳于267秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量减少了2家。
  • 机构持股总比例下降了0.1个百分点。

机构持股

机构持股比例
105.31% -0.11pp
机构数量
342 -2
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund91.95%
Public Company5.50%
Hedge Fund4.98%
Individual/Insider1.77%
Government Pension Fund1.46%
Sovereign Wealth Fund0.71%
Private Company0.44%
Insurance Company0.17%

主要股东 截至 2026-06-30

BlackRock 15.01% · 3.75M 股
Janus Henderson Group plc 11.12% · 2.78M 股
Vanguard Portfolio Management, LLC 5.88% · 1.47M 股
Fuller & Thaler Asset Management, Inc. 5.19% · 1.30M 股
Vanguard Capital Management, LLC 5.16% · 1.29M 股
Dimensional Fund Advisors 4.21% · 1.05M 股
State Street Global Advisors 4.10% · 1.02M 股
Schroder Investment Management North America Inc. 2.88% · 720.64K 股
Columbia Management Investment Advisers, LLC 2.76% · 689.57K 股
Geode Capital Management, LLC 2.64% · 660.42K 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 24次买入 · 26次卖出

姓名职务持股比例
Vivek Jain Chairperson & CEO 1.12%
Brian Bonnell Chief Financial Officer 0.22%
Christian Voigtlander Chief Operating Officer 0.15%
Daniel Woolson Former Corporate VP & GM of Infusion Systems 0.07%
Virginia Sanzone Corporate VP, General Counsel, Secretary & Compliance Officer 0.06%
David Greenberg Lead Independent Director 0.04%
David Hoffmeister Independent Director 0.02%
Donald Abbey Independent Director 0.02%
Elisha Finney Independent Director 0.02%
Laurie Hernandez Independent Director 0.02%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-02 Virginia Sanzone Corporate VP, General Counsel, Secretary & Compliance Officer Automatic Disposition -4,856 $167.67–171.52
2026-08-31 Brian Bonnell Chief Financial Officer Automatic Disposition -6,381 $175.00
2026-08-30 Brian Bonnell Chief Financial Officer Automatic Disposition -9,307 $171.05–173.91
2026-08-12 Daniel Woolson Former Corporate VP & GM of Infusion Systems Open Market Disposition -5,417 $181.33
2026-08-11 Ben Sousa Chief Information Officer Open Market Disposition -2,250 $178.32
2026-08-10 Elisha Finney Independent Director Open Market Disposition -378 $182.48
2026-08-10 Christian Voigtlander Chief Operating Officer Open Market Disposition -8,929 $182.93
2026-05-21 Daniel Woolson Former Corporate VP & GM of Infusion Systems Open Market Disposition -2,123 $132.21
2026-05-13 Virginia Sanzone Corporate VP, General Counsel, Secretary & Compliance Officer Open Market Disposition -2,447 $124.08
2026-05-12 Elisha Finney Independent Director Other Derivative Acquisition +1,475 --
2026-05-12 Elisha Finney Independent Director Derivative Exercise and Retained +1,254 --
2026-05-12 Kolleen Kennedy Independent Director Other Derivative Acquisition +1,475 --
2026-05-12 Kolleen Kennedy Independent Director Derivative Exercise and Retained +1,254 --
2026-05-12 David Hoffmeister Independent Director Other Derivative Acquisition +1,475 --
2026-05-12 David Hoffmeister Independent Director Derivative Exercise and Retained +1,254 --
2026-05-12 Laurie Hernandez Independent Director Other Derivative Acquisition +1,475 --
2026-05-12 Laurie Hernandez Independent Director Derivative Exercise and Retained +1,254 --
2026-05-12 David Greenberg Lead Independent Director Other Derivative Acquisition +1,475 --
2026-05-12 David Greenberg Lead Independent Director Derivative Exercise and Retained +1,254 --
2026-05-12 Donald Abbey Independent Director Other Derivative Acquisition +1,475 --

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

ICU医疗 讨论区 0 条评论

发表评论